Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
3.33M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
1.26K
-
Shares change
-
+675
-
Total reported value, excl. options
-
$7.14K
-
Value change
-
+$3.82K
-
Number of buys
-
7
-
Price
-
$5.88
Significant Holders of ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) as of Q3 2024
8 filings reported holding RSLS - ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share as of Q3 2024.
ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.26K shares
of 3.33M outstanding shares and own 0.04% of the company stock.
Largest 8 shareholders include Tower Research Capital LLC (TRC) (665 shares), BlackRock, Inc. (588 shares), BANK OF AMERICA CORP /DE/ (4 shares), GROUP ONE TRADING LLC (2 shares), MORGAN STANLEY (1 shares), CIBC Private Wealth Group LLC (1 shares), JPMORGAN CHASE & CO (1 shares), and UBS Group AG (1 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.